BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1972140)

  • 1. Selective peripheral dopamine-1 receptor stimulation. Differential responses to sodium loading and depletion in humans.
    Ragsdale NV; Lynd M; Chevalier RL; Felder RA; Peach MJ; Carey RM
    Hypertension; 1990 Jun; 15(6 Pt 2):914-21. PubMed ID: 1972140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of dopamine and fenoldopam effects on renal blood flow and prostacyclin excretion in normal and essential hypertensive subjects.
    Bughi S; Horton R; Antonipillai I; Manoogian C; Ehrlich L; Nadler J
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1116-21. PubMed ID: 2573613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ontogeny of renal response to specific dopamine DA1-receptor stimulation in sheep.
    Segar JL; Smith FG; Guillery EN; Jose PA; Robillard JE
    Am J Physiol; 1992 Oct; 263(4 Pt 2):R868-73. PubMed ID: 1357989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective dopamine DA1 stimulation with fenoldopam in cirrhotic patients with ascites: a systemic, splanchnic and renal hemodynamic study.
    Hadengue A; Moreau R; Bacq Y; Gaudin C; Braillon A; Lebrec D
    Hepatology; 1991 Jan; 13(1):111-6. PubMed ID: 1671029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine DA1 receptor agonist, fenoldopam, reverses glycine-induced hyperfiltration in rats.
    Wang YX; Gellai M; Brooks DP
    Am J Physiol; 1992 Jun; 262(6 Pt 2):F1055-60. PubMed ID: 1352429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of effect of lithium on the renal response to DA1-dopamine receptor stimulation by fenoldopam in normal man.
    Girbes AR; Smit AJ; Meijer S; Reitsma WD
    Br J Clin Pharmacol; 1990 Apr; 29(4):413-5. PubMed ID: 1970264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diuresis and natriuresis during continuous dopamine-1 receptor stimulation.
    Hughes JM; Ragsdale NV; Felder RA; Chevalier RL; King B; Carey RM
    Hypertension; 1988 Feb; 11(2 Pt 2):I69-74. PubMed ID: 2894359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do renal tubular dopamine receptors mediate dopamine-induced diuresis in the anesthetized cat?
    Clark KL; Robertson MJ; Drew GM
    J Cardiovasc Pharmacol; 1991 Feb; 17(2):267-76. PubMed ID: 1709232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dopamine DA1-receptor blockade and angiotensin converting enzyme inhibition on the renal actions of fenoldopam in the anaesthetized dog.
    Clark KL; Hilditch A; Robertson MJ; Drew GM
    J Hypertens; 1991 Dec; 9(12):1143-50. PubMed ID: 1685741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrarenally produced angiotensin II opposes the natriuretic action of the dopamine-1 receptor agonist fenoldopam in rats.
    Chen CJ; Apparsundaram S; Lokhandwala MF
    J Pharmacol Exp Ther; 1991 Feb; 256(2):486-91. PubMed ID: 1671595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tubuloglomerular feedback and blood flow autoregulation during DA1-induced renal vasodilation.
    Pollock DM; Arendshorst WJ
    Am J Physiol; 1990 Mar; 258(3 Pt 2):F627-35. PubMed ID: 1969238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal and endocrine effects of fenoldopam and metoclopramide in normal man.
    Girbes AR; Smit AJ; Meijer S; Reitsma WD
    Nephron; 1990; 56(2):179-85. PubMed ID: 1978736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An impairment of renal tubular DA-1 receptor function as the causative factor for diminished natriuresis to volume expansion in spontaneously hypertensive rats.
    Chen CJ; Lokhandwala MF
    Clin Exp Hypertens A; 1992; 14(4):615-28. PubMed ID: 1352742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fenoldopam is a partial agonist at dopamine-1 (DA1) receptors in LLC-PK1 cells.
    Grenader A; Healy DP
    J Pharmacol Exp Ther; 1991 Jul; 258(1):193-8. PubMed ID: 1677038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dopamine on renal blood flow, prostaglandins, renin and electrolyte excretion in normal and hypertensive humans.
    Horton R; Bughi S; Jost-Vu E; Antonipillai I; Nadler J
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):108S-111S. PubMed ID: 1974438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine-1 and dopamine-2 mechanisms in the control of renal function.
    Carey RM; Siragy HM; Ragsdale NV; Howell NL; Felder RA; Peach MJ; Chevalier RL
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):59S-63S. PubMed ID: 1974444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacology of fenoldopam.
    Nichols AJ; Ruffolo RR; Brooks DP
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):116S-119S. PubMed ID: 1974439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of fenoldopam on the acute and subacute nephrotoxicity produced by amphotericin B in the dog.
    Nichols AJ; Koster PF; Brooks DP; Ruffolo RR
    J Pharmacol Exp Ther; 1992 Jan; 260(1):269-74. PubMed ID: 1346161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DA1 dopamine receptors in renal cortical collecting duct.
    Ohbu K; Felder RA
    Am J Physiol; 1991 Nov; 261(5 Pt 2):F890-5. PubMed ID: 1683170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence from functional and autoradiographic studies for the presence of tubular dopamine-1 receptors and their involvement in the renal effects of fenoldopam.
    Hedge SS; Ricci A; Amenta F; Lokhandwala MF
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1237-45. PubMed ID: 2574743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.